Information:
Fel:
ID
33551
Beskrivning
A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02011945
Länk
https://clinicaltrials.gov/show/NCT02011945
Nyckelord
Versioner (1)
- 2018-12-12 2018-12-12 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
12 december 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Chronic Myeloid Leukemia NCT02011945
Eligibility Chronic Myeloid Leukemia NCT02011945
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Myeloid Leukemia NCT02011945
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Leukemia, Myeloid, Chronic-Phase | Leukemia, Myeloid, Accelerated Phase
Item
confirmed diagnosis of chronic myeloid leukemia in chronic phase or accelerated phase
boolean
C0023474 (UMLS CUI [1])
C0023472 (UMLS CUI [2])
C0023472 (UMLS CUI [2])
Cells Philadelphia chromosome positive
Item
with historically documented ph+ cells
boolean
C0007634 (UMLS CUI [1,1])
C0856536 (UMLS CUI [1,2])
C0856536 (UMLS CUI [1,2])
Protein tyrosine kinase inhibitor therapy Quantity CML
Item
≥2 prior tyrosine kinase inhibitors (tki) therapies for cml
boolean
C0879484 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0023473 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0023473 (UMLS CUI [1,3])
Disease Progression | Resistant to Therapy | Response Suboptimal Therapy
Item
currently progressing, resistance to or with a suboptimal response to their most recent therapy
boolean
C0242656 (UMLS CUI [1])
C0332325 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1704632 (UMLS CUI [3,1])
C2984009 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C0332325 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1704632 (UMLS CUI [3,1])
C2984009 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status (ps) score 0 - 1
boolean
C1520224 (UMLS CUI [1])
Blast Phase CML
Item
blast phase cml
boolean
C0005699 (UMLS CUI [1])
BCR-ABL Mutation Resistant to Dasatinib | T315I mutation | Other Coding
Item
known abl-kinase mutation resistant to dasatinib (e.g. t315i or t315a)
boolean
C0004891 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])
C1455147 (UMLS CUI [1,4])
C3889036 (UMLS CUI [2])
C3846158 (UMLS CUI [3])
C0026882 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])
C1455147 (UMLS CUI [1,4])
C3889036 (UMLS CUI [2])
C3846158 (UMLS CUI [3])